SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 85 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $45,000 | +2.3% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $44,000 | +46.7% | 2,000 | 0.0% | 0.00% | +33.3% |
Q3 2020 | $30,000 | 0.0% | 2,000 | 0.0% | 0.00% | -25.0% |
Q2 2020 | $30,000 | +36.4% | 2,000 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $22,000 | +22.2% | 2,000 | 0.0% | 0.00% | +50.0% |
Q4 2019 | $18,000 | +20.0% | 2,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $15,000 | -21.1% | 2,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $19,000 | +72.7% | 2,000 | 0.0% | 0.00% | +100.0% |
Q1 2019 | $11,000 | +22.2% | 2,000 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $9,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 956,165 | $20,930,000 | 11.19% |
Aisling Capital Management LP | 1,025,000 | $22,437,000 | 7.92% |
FRAZIER MANAGEMENT LLC | 2,772,062 | $60,680,000 | 4.67% |
SPHERA FUNDS MANAGEMENT LTD. | 1,176,585 | $25,755,000 | 2.83% |
Paradigm Biocapital Advisors LP | 453,091 | $9,918,000 | 2.83% |
Ghost Tree Capital, LLC | 300,000 | $6,567,000 | 2.35% |
Avidity Partners Management LP | 4,823,400 | $105,584,000 | 2.24% |
Nantahala Capital Management | 2,850,559 | $62,399,000 | 2.20% |
ACUTA CAPITAL PARTNERS, LLC | 206,126 | $4,512,000 | 1.90% |
BVF INC/IL | 2,099,714 | $45,963,000 | 1.67% |